# PET Study of Repeated ASN51 in Healthy Volunteers

> **NCT05725005** · PHASE1 · COMPLETED · sponsor: **Asceneuron S.A.** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ASN51

## Key facts

- **NCT ID:** NCT05725005
- **Lead sponsor:** Asceneuron S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-26
- **Primary completion:** 2023-04-04
- **Final completion:** 2023-06-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-05-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05725005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05725005, "PET Study of Repeated ASN51 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05725005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*